abstract |
(57) [Summary] [Structure] Formula (I) Wherein R 1 is a C 1 ~ 3 alkyl, C 3 ~ 5 cycloalkyl or C 1 ~ 3 alkyl substituted C 3 ~ 5 cycloalkyl, R 2 is morpholino, thiomorpholino, thiomorpholino S, with S- dioxide, etc. A substituted cyclopropylamino-1,3,5-triazine compound, a method for producing the same, and a pharmaceutical composition containing the compound as an active ingredient. [Effect] The compound of the present invention exhibits excellent effects in treating Alzheimer's disease, depression, inflammation and the like. |